Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5776847

CCN1CCN(C(=O)CCc2cnoc2-c2ccc(F)cc2)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 1/20 0.39
ALOX5 P09917 2/20 0.38
CACNA1F O60840 1/20 0.38
HTR1A P08908 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
DRD4 P21917 1/20 0.38
DRD5 P21918 1/20 0.38
HRH2 P25021 1/20 0.38
ADRA1D P25100 1/20 0.38
HTR2A P28223 1/20 0.38
HTR7 P34969 1/20 0.38
ADRA1A P35348 1/20 0.38
HRH1 P35367 1/20 0.38
ADRA1B P35368 1/20 0.38
OPRM1 P35372 1/20 0.38
DRD3 P35462 1/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
HTR6 P50406 1/20 0.38
CACNA1D Q01668 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5776834 0.90 HTT (0.46) ALOX5CACNA1FHTR1AADORA3DRD4
Trifluoroacetic Acid SCHEMBL5772964 0.90 TSHR (0.45) ALOX5CACNA1FHTR1AADORA3DRD4
Trifluoroacetic Acid SCHEMBL5770006 0.89 KDM4E (0.39) ALOX5CACNA1FHTR1AADORA3DRD4
Trifluoroacetic Acid SCHEMBL5776822 0.88 DPP8 (0.50) ALOX5DPP8DPP7GFERMEN1
Trifluoroacetic Acid SCHEMBL5777433 0.87 GFER (0.53) GFERMEN1KMT2AALDH1A1MAPT
Trifluoroacetic Acid SCHEMBL5772610 0.86 GFER (0.53) GFERMEN1KMT2AMAPTTSHR
Trifluoroacetic Acid SCHEMBL5776691 0.84 GRM5 (0.48) HTR1ADRD4HTR2AHTR7HRH1
Trifluoroacetic Acid SCHEMBL5773395 0.84 LMNA (0.48) HTR1AADORA3ADRA1DHTR2AADRA1A
Trifluoroacetic Acid SCHEMBL5773386 0.84 LMNA (0.48) HTR1AADORA3ADRA1DHTR2AADRA1A
Trifluoroacetic Acid SCHEMBL5770044 0.84 RXFP1 (0.49) GFERMEN1KMT2AL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR MDM2 4697/4885ALOX5 985/4885CACNA1F 1585/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 MDM2 4707/4885ALOX5 1281/4885CACNA1F 1142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.